Kopran

Recommended Earlier and moved from 33 to 46, repeated again and reproducing the report.

Once Kopran was the largest manufacturer of Amoxicillin in India and it was the feather in the cap of Parijat Group led by somanis. In 1994 its share price touched a high of Rs.830/-.Its name later heard in association with KP stocks scam along with other companies like Ranbaxy, Cadilla, Nirma ..etc.Anyway after that Kopran sold off its prestige brands like `Smile` to other companies and its share price nosedives even to Rs.6/- . Later all Parijat group companies (Oricon Enterprises, Kopran and Excel Glasses) goes through severe working capital crunch. In 2007 Parijat group started its efforts to revive their companies one by one with the help of Clearwater capital partners (a P/E fund specializing in reviving ailing companies due to lack of sufficient working capital)and fresh fund infusion by promoters . As aresult of these efforts On better financial performance , share price of Oricon Enterprises moved from a one year low of Rs.20/- to the current level of Rs.360/-. After the case of Oricon, Kopran is now showing signs of some revival.After a long time company has posted some promising results in December qtr. Company posted a turnover of Rs.40 crore v/s 30 crore and net profit of Rs.1.12 crore v/s a loss of 6.6 crore in this December qtr compared with last year same qtr. It seems to be an early indication of some good days ahead .Now company decided to focusing on international markets through its formulations and API`s business. If you have some patience, add some doze of Kopran in your portfolio. This may turn to be another multibagger....

This was my earlier recommendation.

After results declared Company posted a turnover of Rs.156 crore v/s 115 crore and net profit of Rs. 9.5 crore v/s a loss of 13 crore in this last financial year. It seems to be an early indication of some good days ahead. Now company decided to focusing on international markets through its formulations and API`s business. If you have some patience, add some doze of Kopran in your portfolio. This may turn to be another multibagger.... EPS of 2.5 vs negative EPS of 3.8 last year.